With $5M Grant, Rogel Team Will Conduct Preclinical Work to Develop Drugs Targeting Cancer Master Regulator
April 30, 2024
April 30, 2024
ANN ARBOR, Michigan, April 30 (TNSres) -- The University of Michigan's Rogel Cancer Center issued the following news release:
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.
The SWI/SNF chroma . . .
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.
The SWI/SNF chroma . . .